SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-034157
Filing Date
2019-02-11
Accepted
2019-02-11 17:18:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d660880ds3a.htm S-3/A 408741
2 EX-23.1 d660880dex231.htm EX-23.1 1566
3 GRAPHIC g660880g65y11.jpg GRAPHIC 52772
  Complete submission text file 0001193125-19-034157.txt   484049
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-228967 | Film No.: 19586537
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1